Navigation Links
FDA News & Notes - Week of July 25, 2011
Date:7/25/2011

SILVER SPRING, Md., July 25, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of July 25, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Events and Speeches for the Commissioner and FDA leadership:
Tuesday, 7/26 – FDA Commissioner Margaret Hamburg speaks at the amfAR Capitol Hill Summit held to mark the progress that has been made in the fight against the disease. 1 p.m., Kennedy Caucus Room (R-325), Russell Senate Office Building, Constitution Ave. and Delaware Ave., N.E., Washington, D.C. Space is limited. RSVP to AIDSConference@hayespr.com or call 703-288-8696.
Press Office Contact: Raymond Formanek Jr., 301-796-4677, raymond.formanek@fda.hhs.gov

Meetings, Workshops and Congressional Testimony:
Tuesday, 7/26 – The FDA's Pharmaceutical Science and Clinical Pharmacology Advisory Committee discusses bioequivalence and quality standards for narrow therapeutic index drug products. 8 a.m., 10903 New Hampshire Ave., Building 31, Room 1503, Silver Spring, Md.
Press Office Contact: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov

Wednesday, 7/27 – The FDA's Pharmaceutical Science and Clinical Pharmacology Advisory Committee considers strategies for the implementation of quality by design principles within the Office of Pharmaceutical Science review offices. 8 a.m., 10903 New Hampshire Ave, Building 31, Room 1503, Silver Spring, Md.
Press Office Contact: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov

Wednesday, 7/27 – American Telemedicine Association Policy Summit
Bakul Patel, policy adviser, and Mary Brady, senior policy analyst, from the Center for Devices and Radiological Health speak on mobile health policy and telehealth. 8:30 a.m., The Westin Washington, D.C., 1400 M Street, N.W., Washington, D.C.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Thursday, 7/28 – FDA Commissioner Hamburg testifies before the Senate Committee on Health, Education, Labor and Pensions on "FDA User Fees: Advancing Public Health." 9:45 a.m., Dirksen Senate Office Bldg., Constitution Ave. and 1st St., N.E., Room 430, Washington, D.C.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Monday, 8/1 –  The first FDA Humanitarian Use Device Workshop provides an opportunity to spend two days developing applications for devices intended to treat or diagnosis a rare disease or condition. 8 a.m., University of Minnesota-Twin Cities Campus, Moos Tower, 515 Delaware Street, S.E., Minneapolis.
Press Office Contact: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov

On the Web:
Tuesday, 7/26 – The FDA begins a pilot program seeking to expedite notifications of human drug product recalls to the public. The agency will modify the drug product section of the Enforcement Report, published every Wednesday, to include actions that have been determined to be recalls, but that remain in the process of being classified as a Class I, II, or III action. Such recalls will be listed under the heading, "Recalls Pending Classification: DRUGS." They will be reposted with their classification once that determination has been made. Send comments or suggestions to RecallPilot@fda.hhs.gov.
Press Office Contact: Shelly Burgess, 301-796-4651, shelly.burgess@fda.hhs.gov

Analysis of Premarket Review Times Under the 510(k) Program at Center for Devices and Radiological Health.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Guidance for Industry and FDA Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza Viruses
Press Office Contact: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov

FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov
List of FDA press officers and beats

More Resources:
FDA News and Events
FDA Photos (Flickr)
Consumer Health Information


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Robbins & Myers Announces Regular Quarterly Cash Dividend
6. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
7. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
8. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
9. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
10. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
11. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... its first patient in a Phase 1 study of ... (ADN) that encapsulates a novel taxane and targets the ... in 50-100% of many major tumor types, including prostate, ... "The initiation of this study is an important step ...
(Date:3/23/2017)... WINNIPEG , March 23, 2017 /PRNewswire/ - ... a leading Canadian specialty pharmaceutical company, is pleased ... has received final approval from the U.S. Food ... new drug application ("ANDA") for tetrabenazine tablets in ... newly approved product is a generic equivalent of ...
(Date:3/23/2017)... SANTA MONICA, Calif. , March 23, 2017 /PRNewswire/ ... the launch of a native mobile app for the ... the standard for surgery coordination and communication for physician ... of a native mobile app offers iPhone users even ... "Casetabs is making it even easier to connect ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of Buzzies ... stress and anxiety. , “Buzzies change the way we interact with stress and ... , Since its launch date in December 2016, The TouchPoint Solution has sold more ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... 23, 2017 , ... It’s that time of year again! Time to think ... summer internships , which can be frustrating when they don’t even know how to ... a boutique public relations firm outside of Philadelphia, have offered these three tips to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... skincare products, was awarded as winners of American Dreams & Good Housekeeping Seal ... hosted jointly by HSN and Good Housekeeping. , Steven Wang, MD ., ...
(Date:3/23/2017)... , ... March 23, 2017 , ... News Advisory/Interview Opportunity ... has helped score a major victory in Europe for public health and the environment ... , Based on rigorous scientific research and the overwhelming support of European citizens, the ...
Breaking Medicine News(10 mins):